Home›People›Jasmina Marjanovic
JM

Jasmina Marjanovic

Director at EvolveImmune Therapeutics Holding Company.

Director
Updated Nov 15, 2026·Latest SEC filing Nov 1, 2024·Suggest an edit

About Jasmina Marjanovic

Form D filings for EvolveImmune Therapeutics Holding Company in 2024 list Jasmina Marjanovic as director.

Jasmina Marjanovic first appears on SEC filings in 2024.

Experience

This experience comes from SEC filings. The years are when the filings name Jasmina Marjanovic in the role, so the role may have started earlier or lasted longer.

EvolveImmune Therapeutics Holding Company, LLC
Director
2024 · Branford, CT
Develops immune-based cancer treatments for patients with solid tumors and blood cancers.

Key Colleagues at Startups

The people Jasmina Marjanovic works with at each company, as listed on that company's latest Form D.

IT
Ian Taylor
Director
DY
Derek Yoon
Director
SB
Stephen Bloch
Co-founder and Chief Executive Officer, director
DP

Sources

  1. SECEvolveImmune Therapeutics Holding Company, LLC Form D, filed Nov 1, 2024